Incyte: Why Wait For ASCO…Cancer Drug Data Incites Investors
May 18, 2017 at 12:57 PM EDT
Incyte's share price is on the rise today after data regarding its new cancer drug released ahead of next month's ASCO meeting exceeded expectations.
